Jackson
发表于 2025-3-21 17:23:10
书目名称Non-Vitamin K Antagonist Oral Anticoagulants影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0667058<br><br> <br><br>书目名称Non-Vitamin K Antagonist Oral Anticoagulants读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0667058<br><br> <br><br>
水土
发表于 2025-3-21 23:26:37
http://image.papertrans.cn/n/image/667058.jpg
北京人起源
发表于 2025-3-22 04:25:47
https://doi.org/10.1007/978-3-319-25460-9Atrial Fibrillation; Coagulation; Factor Xa; Thromboembolism; Stroke; Acute Coronary Syndromes
冰河期
发表于 2025-3-22 05:09:08
http://reply.papertrans.cn/67/6671/667058/667058_4.png
不安
发表于 2025-3-22 08:59:10
http://reply.papertrans.cn/67/6671/667058/667058_5.png
和谐
发表于 2025-3-22 13:54:45
http://reply.papertrans.cn/67/6671/667058/667058_6.png
endoscopy
发表于 2025-3-22 17:55:57
http://reply.papertrans.cn/67/6671/667058/667058_7.png
Salivary-Gland
发表于 2025-3-22 23:25:19
http://reply.papertrans.cn/67/6671/667058/667058_8.png
反叛者
发表于 2025-3-23 02:21:40
http://reply.papertrans.cn/67/6671/667058/667058_9.png
诱使
发表于 2025-3-23 06:25:25
Conclusions,rillation (AF) and the prevention of recurrent venous thromboembolism (VTE) . These meta-analyses were the first to include data for all four NOACs studied in pivotal phase III studies for these indications.